Forte Biosciences Ownership | Who Owns Forte Biosciences?

Forte Biosciences Ownership Summary

Forte Biosciences is owned by 11.52% institutional investors, 4.96% insiders, and 83.52% retail investors. Fred alger management is the largest institutional shareholder, holding 14.20% of FBRX shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 5.14% of its assets in Forte Biosciences shares.

FBRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Forte Biosciences	11.52%	4.96%	83.52%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fred alger management	1.62M	14.20%	$20.93M
Orbimed advisors	1.20M	10.50%	$15.48M
Tybourne capital management (hk)	786.65K	6.90%	$10.17M
Bvf inc/il	588.34K	5.16%	$7.61M
Cable car capital	500.00K	4.39%	$6.46M
Sphera funds management	495.11K	4.34%	$6.40M
Ikarian capital	476.44K	4.18%	$6.16M
Adage capital partners gp	333.33K	2.92%	$4.31M
Heights capital management	143.03K	1.25%	$1.85M
Geode capital management	346.29K	0.75%	$186.01K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tybourne capital management (hk)	786.65K	29.45%	$10.17M
Cable car capital	500.00K	2.07%	$6.46M
Sphera funds management	495.11K	1.50%	$6.40M
Ikarian capital	476.44K	1.18%	$6.16M
Heights capital management	143.03K	0.49%	$1.85M
Orbimed advisors	1.20M	0.39%	$15.48M
Bvf inc/il	588.34K	0.27%	$7.61M
Fred alger management	1.62M	0.09%	$20.93M
Perceptive advisors	68.19K	0.03%	$881.72K
Quest partners	16.90K	0.02%	$218.48K

Top Buyers

Holder	Shares	% Assets	Change
Fred alger management	1.62M	0.09%	708.04K
Orbimed advisors	1.20M	0.39%	603.87K
Sphera funds management	495.11K	1.50%	495.11K
Adage capital partners gp	333.33K	0.01%	333.33K
Cable car capital	500.00K	2.07%	280.40K

Top Sellers

Holder	Shares	% Assets	Change
Bml capital management	-	-	-1.76M
Vanguard group	-	-	-665.23K
Adar1 capital management	-	-	-159.26K
Renaissance	-	-	-133.40K
Ikarian capital	476.44K	1.18%	-132.78K

New Positions

Holder	Shares	% Assets	Change	Value
Sphera funds management	495.11K	1.50%	495.11K	$6.40M
Adage capital partners gp	333.33K	0.01%	333.33K	$4.31M
Heights capital management	143.03K	0.49%	143.03K	$1.85M
Susquehanna group, llp	34.34K	-	34.34K	$18.44K
Envestnet asset management	18.86K	0.00%	18.86K	$243.81K

Sold Out

Holder	Change
Jpmorgan chase	-3.00
Qube research	-3.00
Fmr	-128.00
Loring wolcott & coolidge fiduciary advisors llp/ma	-193.00
Wells fargo & company/mn	-253.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	7	-75.86%	1,313,474	-73.91%	11	0.59%	5	-61.54%	-	-100.00%
Mar 31, 2025	29	11.54%	5,034,503	17.74%	44	0.21%	13	-13.33%	4	-
Dec 31, 2024	26	13.04%	4,275,837	480.46%	146	9.23%	15	650.00%	4	-80.95%
Sep 30, 2024	23	-32.35%	736,630	-96.14%	39	2.33%	2	-80.00%	21	250.00%
Jun 30, 2024	33	3.13%	19,068,395	0.10%	41	1.14%	10	42.86%	6	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann Growth	628.21K	5.14%	628.21K
Federated Hermes Kaufmann R	628.21K	5.14%	628.21K
Alger Small Cap Focus Composite	463.42K	3.73%	286.55K
Alger Small Cap Focus I	463.42K	3.73%	286.55K
Federated Hermes Kaufmann Small Cap A	426.49K	3.49%	426.49K
Federated Hermes Kaufmann Small Cap Grow	426.49K	3.49%	426.49K
Vanguard Total Stock Mkt Idx Inv	371.88K	3.03%	-8.20K
Alger LIfe Sciences Innovation Composite	166.65K	1.34%	-11.69K
Alger Large Cap Growth Composite	158.02K	1.27%	89.55K
Alger Large Cap Growth I-2	158.02K	1.27%	89.55K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 21, 2024	Riley Antony A	CHIEF FINANCIAL OFFICER	Buy	$125.00K
Dec 18, 2023	Wagner Paul A.	See Remarks	Buy	$7.53K
Dec 13, 2023	Wagner Paul A.	See Remarks	Buy	$7.35K
Dec 14, 2023	Wagner Paul A.	See Remarks	Buy	$7.20K
Dec 11, 2023	Wagner Paul A.	See Remarks	Buy	$16.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	1	-

FBRX Ownership FAQ

Who Owns Forte Biosciences?

Forte Biosciences shareholders are primarily institutional investors at 11.52%, followed by 4.96% insiders and 83.52% retail investors. The average institutional ownership in Forte Biosciences's industry, Biotech Stocks , is 307.10%, which Forte Biosciences falls below.

Who owns the most shares of Forte Biosciences?

Forte Biosciences’s largest shareholders are Fred alger management (1.62M shares, 14.20%), Orbimed advisors (1.2M shares, 10.50%), and Tybourne capital management (hk) (786.65K shares, 6.90%). Together, they hold 31.60% of Forte Biosciences’s total shares outstanding.

Does Blackrock own Forte Biosciences?

BlackRock is not among the top 10 institutional shareholders of Forte Biosciences.

Who is Forte Biosciences’s biggest shareholder by percentage of total assets invested?

Tybourne capital management (hk) is Forte Biosciences’s biggest shareholder by percentage of total assets invested, with 29.45% of its assets in 786.65K Forte Biosciences shares, valued at 10.17M$.

Who is the top mutual fund holder of Forte Biosciences shares?

Federated Hermes Kaufmann Growth is the top mutual fund holder of Forte Biosciences shares, with 5.14% of its total shares outstanding invested in 628.21K Forte Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools